Bernstein, Barry M.,Dutta, Sandeep,Liu, Wei,Podsadecki, Thomas J.,Campbell, Andrew L.,Menon, Rajeev M.,Lin, Chih-Wei,Wang, Tianli,Awni, Walid M.
申请号:
AU2016202823
公开号:
AU2016202823A1
申请日:
2016.05.03
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
#$%^&*AU2016202823A120160519.pdf#####COMBINATION OF TWO ANTIVIRALS FOR TREATING HEPATITIS C ABSTRACT The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection, wherein the treatment lasts for 12 weeks, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.